Results 131 to 140 of about 1,433 (142)

Transformative therapies for sickle cell disease. [PDF]

CMAJ
Jamani K, Chopek A, Kumar R, Guilcher GMT.   +3 more
europepmc   +1 more source

User engagement with home blood pressure monitoring: a multinational cohort using real-world data collected with a connected device. [PDF]

J Hypertens
Rech JS, Postel-Vinay N, Vercamer V, de Villèle P, Steichen O.   +4 more
europepmc   +1 more source

Acceptability, barriers and facilitators of using dried blood spots-point-of-care testing for sickle cell disease in Africa: an implementation science protocol for a multinational qualitative study. [PDF]

BMJ Open
Nnodu OE, Munung NS, Chirande L, Chunda-Liyoka C, Kiguli S, Sarfo FS, Touré BA, Balandya E, Guindo A, Kuona P, Esoh K, Jonas M, Nwegbu M, Masamu U, Morrice J, Moru PO, Bitoungui VN, Nembaware V, Nkya S, Tshilolo L, Makani J, Wonkam A, Peprah E, SickleInAfrica Consortium.   +23 more
europepmc   +1 more source

Determination of the Level of von Willebrand Factor, ADAMTS13, and Ratio of ADAMTS13:von Willebrand Factor in Sickle Cell Disease Patients.

Ann Afr Med
Onorhide AK, Idongesit AS, Olanrewaju OP.   +2 more
europepmc   +1 more source